Welcome to our dedicated page for Peraso SEC filings (Ticker: PRSO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Peraso Inc. (NASDAQ: PRSO) SEC filings page on Stock Titan provides centralized access to the company’s regulatory disclosures, drawn from the U.S. Securities and Exchange Commission’s EDGAR system. Peraso is a fabless semiconductor company focused on 60 GHz unlicensed and 5G mmWave wireless technology, and its filings offer detailed insight into its capital structure, governance, financing activities and financial performance.
Investors can review Form 10‑K annual reports and Form 10‑Q quarterly reports to understand how Peraso describes its business, risk factors and results of operations, including its focus on mmWave chipsets, antenna modules, software and IP. These core filings typically include segment information, discussion of fixed wireless access and other applications, and management’s analysis of revenue, expenses and non-GAAP metrics.
Peraso’s frequent Form 8‑K current reports document material events such as earnings releases, strategic review updates, prospectus supplements for at-the-market equity offerings, changes in outstanding securities, and governance matters. For example, 8‑K filings describe the company’s ongoing strategic review and interactions with Mobix Labs, amendments to its Amended and Restated 2019 Stock Incentive Plan, the appointment of director Cees Links, and notices related to regaining compliance with Nasdaq’s minimum bid price requirement.
This page also surfaces registration statements and prospectus supplements that outline Peraso’s at-the-market offering program, as well as disclosures on outstanding warrants, stock options, restricted stock units and the Series A special voting preferred stock. Where available, Form 4 insider transaction reports can be used to track equity transactions by directors and officers.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as changes in capital structure, non-GAAP reconciliations, board and committee changes, and updates on strategic alternatives. Real-time updates ensure that new Peraso filings appear promptly, giving investors an efficient way to follow the company’s regulatory history and ongoing reporting.
Peraso Inc. granted new equity incentives to its top executives. On February 9, 2026, the compensation committee awarded 60,000 stock options each to Chief Executive Officer Ronald Glibbery, Chief Financial Officer James Sullivan, and Chief Operating Officer Bradley Lynch.
The options have an exercise price of $0.87 per share, vest in equal monthly installments over 36 months starting one month after the grant date, and expire on February 9, 2036. These awards were made under Peraso’s Amended and Restated 2019 Stock Incentive Plan.
Peraso Inc. reported that its Chief Financial Officer, James Sullivan, received a grant of 60,000 stock options on February 9, 2026. These options have an exercise price of $0.87 per share and were awarded at no cost to him.
The options vest as to 1/36th of the shares each month starting after February 9, 2026, creating a roughly three-year vesting schedule. Following this grant, Sullivan beneficially owns 60,000 derivative securities of this option class, all held directly.
Peraso Inc. granted Chief Executive Officer and director Ronald Glibbery a stock option covering 60,000 shares of common stock at an exercise price of $0.87 per share on February 9, 2026.
The option vests in equal monthly installments, with 1/36th of the shares vesting on each monthly anniversary following February 9, 2026, and expires on February 9, 2036. Following this grant, Glibbery beneficially owns 60,000 derivative securities of this option class, held directly.
Peraso Inc. reported that Chief Operating Officer Brad Lynch received a grant of stock options on February 9, 2026. The award covers 60,000 stock options with an exercise price of $0.87 per share, allowing future purchases of Peraso common stock at that price.
The options begin vesting after February 9, 2026. They will vest in equal monthly installments, with 1/36th of the shares vesting on each monthly anniversary until fully vested. The options are scheduled to expire on February 9, 2036 if not exercised.
Peraso Inc. reported that Chief Technology Officer Alex Tomkins received a grant of stock options on February 9, 2026. The award covers 60,000 stock options with an exercise price of $0.87 per share, all held as direct ownership.
The options relate to Peraso common stock and begin vesting after February 9, 2026. The grant will vest as to 1/36th of the shares each month following that date, so the award vests gradually over three years, aligning the CTO’s compensation with longer-term company performance.
Peraso Inc. director Links Cornelis reported new equity awards received on January 7, 2026. He was granted 50,000 restricted stock units (RSUs) of common stock at no cash cost, increasing his directly held common shares to 50,025 after the grant.
The RSU award vests in full on January 7, 2027 or earlier if the next annual stockholders’ meeting occurs before that date. Cornelis was also granted a stock option for 100,000 shares of common stock with a $1 exercise price, held directly. One-third of this option vests on the first anniversary of the grant, and the remaining two-thirds vest quarterly over the following two years, leaving him with 100,000 stock options outstanding.
Peraso Inc. director files initial ownership report. Director Links Cornelis filed a Form 3 showing beneficial ownership of 25 shares of Peraso Inc. common stock as of the event date. The shares are held directly, and no derivative securities or additional holdings are reported.
Peraso Inc. reported that it continues to hold discussions with Mobix Labs, Inc. about a potential strategic transaction. The two companies are operating under a mutual confidentiality agreement originally signed on October 30, 2025 and are conducting customary, confidential due diligence.
Mobix Labs has provided Peraso with a non-binding indication of interest for a possible all-stock transaction at a premium to Peraso’s current trading price. This indication remains subject to further diligence, negotiation, and the signing of definitive agreements, and there is no agreement yet on structure, consideration, timing, or other key terms. Peraso also cautions that any statements about potential deals, strategic rationale, or expected benefits are forward-looking and may differ materially from actual outcomes.
Peraso Inc. director Robert Y. Newell IV reported receiving an equity grant in the form of restricted stock units. On January 7, 2026, he was awarded 50,000 RSUs, recorded at a price of $0.00 per share, reflecting a compensatory grant rather than a market purchase. Each RSU represents the right to receive one share of Peraso common stock once the award vests.
The entire RSU award vests and becomes non‑forfeitable on January 7, 2027, or earlier if Peraso’s next annual meeting of stockholders occurs before that date. Following this grant, Newell is reported as directly beneficially owning 53,947 shares of Peraso common stock.
Peraso Inc. director Lewis Daniel Lee reported an equity award in the form of restricted stock units. On January 7, 2026, he received 50,000 shares of Peraso common stock at a price of $0.00, reported as an acquisition of non-derivative securities. The filing explains this is a restricted stock unit (RSU) grant, where each RSU represents a contingent right to receive one common share once vested.
The entire RSU award is scheduled to vest and become non-forfeitable on January 7, 2027, or earlier if Peraso holds its next annual meeting of stockholders before that date. After this grant, Lee beneficially owned 54,292 shares of Peraso common stock directly. This transaction reflects an equity-based compensation award rather than an open-market purchase.